Tuesday, May 21, 2024

Smart Blood Analytics Achieves EU-MDR Certification for Clinical Software: A Milestone in Fighting Antimicrobial Resistance

Smart Blood Analytics, based in Switzerland, celebrates a significant achievement with its recent attainment of European Medical Device Regulation (EU-MDR) certification for its VIRUS versus BACTERIA Clinical Decision Support Software.

This milestone marks a pivotal advancement in combating antimicrobial resistance (AMR), a pressing global health issue exacerbated by the misuse of antibiotics. The VIRUS versus BACTERIA software, leveraging 17 routine blood parameters alongside factors such as biological sex and age, accurately discerns between viral and bacterial infections. This precision equips healthcare providers with the necessary insights to administer targeted treatments, thereby mitigating the overuse of antibiotics and curbing AMR’s escalation.

CEO Dr. Marko Notar emphasizes the software’s role in empowering clinicians with comprehensive diagnostic tools, aligning with global initiatives prompted by the 2022 G20 Bali summit’s call to action against AMR. The EU-MDR certification process, known for its stringent standards, underscores the software’s adherence to safety, quality, and regulatory compliance, ensuring its efficacy in healthcare settings worldwide.

With its user-friendly interface and rigorous certification, VIRUS versus BACTERIA stands as a beacon of hope in the battle against AMR, promising to revolutionize antibiotic prescribing practices and safeguard public health on a global scale.

Related Articles

Latest Articles

Most Popular